CN Patent

CN113816917B — 一种维贝格龙中间体的制备方法

Assigned to Aoruite Pharmaceutical Tianjin Co ltd · Expires 2022-02-18 · 4y expired

What this patent protects

本发明公开了一种维贝格龙中间体的制备方法。本发明的制备方法所用原料不存在剧毒品和易燃品，对环境友好，纯化简单，收率高，有利于工业化生产。

USPTO Abstract

本发明公开了一种维贝格龙中间体的制备方法。本发明的制备方法所用原料不存在剧毒品和易燃品，对环境友好，纯化简单，收率高，有利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN113816917B
Jurisdiction
CN
Classification
—
Expires
2022-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Aoruite Pharmaceutical Tianjin Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.